프레스티지바이오로직스, 24억원 원료의약품 위탁생산계약 체결

Prestige Biologics secured a 24 billion won API contract manufacturing deal representing 19.15% of recent revenue, demonstrating its expanded production capabilities and technological competitiveness. The technology transfer-based contract strengthens the company's position as a specialized contract manufacturer in the pharmaceutical sector. This deal validates revenue diversification and Prestige Biologics' growing significance in the global pharmaceutical outsourcing market.